KMTS vs WST · rev $95.1M vs P/E 35, rev $1.72B
Kestra Medical Technologies, Ltd. Common Stock (KMTS) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported KMTS revenue for 2026-04-30 was $95.1M. Net income was -$131.6M. Revenue was up 59.0% from 2025-04-30 to 2026-04-30. KMTS currently screens at market cap $1.24B.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
KMTS currently screens at market cap $1.24B. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the KMTS and WST stock pages for the full models.
Not investment advice.